Calando Pharmaceuticals (United States)

Recent papers from Calando Pharmaceuticals (United States)

1. Phase 1/2 study of CLIO-8221, a HER2-targeted, dual-payload exatecan and ATR inhibitor antibody-drug conjugate (ADC) in patients with advanced HER2-expressing solid tumors.Journal of Clinical Oncology · 2026
2. Testing a Sustainable Strategy Against Poultry Helminth Stages Developing in the SoilPathogens · 2025
3. Divergent sex-specific effects on a ketogenic diet: Male, but not female, mice exhibit oxidative stress and cellular senescenceCell Reports · 2025
4. A Phase 2A randomized, double-blind, placebo-controlled pilot trial of GM604 in patients with Amyotrophic Lateral Sclerosis (ALS Protocol GALS-001) and a single compassionate patient treatment (Protocol GALS-C)F1000Research · 2017
5. Types of Nanocarriers–Formulation Method and ApplicationsJournal of Bioequivalence & Bioavailability · 2017
6. Fentanyl Sublingual Spray for Breakthrough Cancer Pain in Patients Receiving Transdermal FentanylPain Management · 2016
7. Database reverse engineering method2013
8. Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticleProceedings of the National Academy of Sciences · 2013
9. Cyclodextrin-Containing Polymers: Versatile Platforms of Drug Delivery MaterialsJournal of Drug Delivery · 2012
10. TARGETED DELIVERY OF siRNA TO CELL DEATH PROTEINS IN SEPSISShock · 2009
11. Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurementsProceedings of the National Academy of Sciences · 2009
12. Preclinical Results of Camptothecin-Polymer Conjugate (IT-101) in Multiple Human Lymphoma Xenograft ModelsClinical Cancer Research · 2009
13. Polymeric Tubulysin-Peptide Nanoparticles with Potent Antitumor ActivityClinical Cancer Research · 2008
14. α-Methylprednisolone conjugated cyclodextrin polymer-based nanoparticles for rheumatoid arthritis therapyInternational Journal of Nanomedicine · 2008
15. Cooperative catalysis by silica-supported organic functional groupsChemical Society Reviews · 2008
16. Potent siRNA Inhibitors of Ribonucleotide Reductase Subunit RRM2 Reduce Cell Proliferation In vitro and In vivoClinical Cancer Research · 2007
17. Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNAProceedings of the National Academy of Sciences · 2007
18. Consequences of Diagnostic Delays in Type 1 Gaucher Disease: A Unique Opportunity among Hematologists/Oncologists for Early Diagnosis and Intervention.Blood · 2006
19. Structure−Function Correlation of Chloroquine and Analogues as Transgene Expression Enhancers in Nonviral Gene DeliveryJournal of Medicinal Chemistry · 2006
20. Linear cyclodextrin-containing polymers and their use as delivery agentsExpert Opinion on Drug Delivery · 2006